Trial intelligence / Profile preview

Sumamed Phase IV study for respiratory tract infections in adults and children

ISRCTN38391551Phase 4Completed

Sponsor
PLIVA
Start
Jun 2008
Modality
Small Molecules
01

Overview

Phase 4, open-label trial of azithromycin in bacterial airway infections, acute pharyngitis, tonsillitis and 4 more (2 arms), sponsored by PLIVA. Primary endpoint: Clinical efficacy. Started Jun 2008; status: completed.

02

Drugs

azithromycin
03

Conditions

bacterial airway infectionsacute pharyngitistonsillitisacute rhinosinusitis (ARS)acute otitis media (AOM)

Beyond the preview

Go deeper on ISRCTN38391551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN38391551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call